Table 3.
Chi square comparative HIV treatment outcomes among the study patients by PI prescription
| Appropriate PI prescription n (%) | Inappropriate PI prescription n (%) | p-value | |
|---|---|---|---|
| 2-year post TB treatment HIV clinical outcome (N = 248) | N = 21 | N = 227 | 0.318 |
| Alive in care | 13 (61.9) | 146 (64.3) | |
| Dead | 1 (4.8) | 13 (5.7) | |
| LTFU | 5 (23.8) | 43 (18.9) | |
| TO | 2 (9.5) | 25 (11.0) | |
| Missed ART days during TB treatment, (N = 602) | N = 103 | N = 499 | 0.001 |
| None | 66 (64.1) | 394 (79.0) | |
| Missed | 37 (35.9) | 105 (21.0) | |
|
Closest viral load post TB treatment (within 1 year) ( N = 218) |
N = 19 | N = 199 | 0.471 |
| Suppressed | 13 (68.4) | 138 (69.4) | |
| Virologic failure | 6 (31.6) | 61 (30.7) |
LTFU loss to follow up, TO Transferred out, Appropriate PI prescription LPV/r 800/ 200 mg BID, inappropriate PI prescription prescription of LPV/r 400/100 mg BID or a prescription of ATV/r, ART Antiretroviral therapy